Resmed Inc banner

Wall St Price Targets

RSMDF Price Targets Summary
Resmed Inc

Wall Street analysts forecast RSMDF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RSMDF is 32.91 USD with a low forecast of 5.49 USD and a high forecast of 42.31 USD.

Lowest Forecast
Price Target
5.49 USD
78% Downside
Average Forecast
Price Target
32.91 USD
32% Upside
Highest Forecast
Price Target
42.31 USD
70% Upside
Resmed Inc Competitors:
Price Targets
PHUN
Phunware Inc
202% Upside
LEG
Leggett & Platt Inc
13% Upside
UMBF
UMB Financial Corp
12% Upside

Revenue
Forecast

11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.

Operating Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.

Net Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RSMDF's stock price target?
Price Target
32.91 USD

According to Wall Street analysts, the average 1-year price target for RSMDF is 32.91 USD with a low forecast of 5.49 USD and a high forecast of 42.31 USD.

What is the Revenue forecast for Resmed Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.

What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.

What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett